Literature DB >> 2413082

Membrane phenotypic studies in B cell lymphoproliferative disorders.

C S Scott, H J Limbert, I D MacKarill, B E Roberts.   

Abstract

A total of 398 cases of B cell lymphoproliferative disease were phenotypically characterised by membrane mouse red blood cell (MRBC) receptor, surface immunoglobulin, common acute lymphoblastic leukaemia (CALLA), and FMC7 and T1 monoclonal antibody studies. Relations between chronic lymphocytic leukaemia (CLL), prolymphocytic leukaemia (PLL), and "prolymphocytoid" CLL variants were examined with particular reference to the expression of FMC7. In addition, the reactivity of TU1 monoclonal antibody with B cell disorders was established. The results suggest that despite some heterogeneity most cases may be characterised by their phenotypic patterns and that these investigations provide a reproducible basis for classification.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413082      PMCID: PMC499348          DOI: 10.1136/jcp.38.9.995

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies.

Authors:  M Gobbi; F Caligaris-Cappio; G Janossy
Journal:  Br J Haematol       Date:  1983-07       Impact factor: 6.998

2.  The nature of hairy cells - a study with a panel of monoclonal antibodies.

Authors:  C P Worman; D A Brooks; N Hogg; H Zola; P C Beverley; J C Cawley
Journal:  Scand J Haematol       Date:  1983-03

3.  Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytoma.

Authors:  K H Robèrt; G Juliusson; P Biberfeld
Journal:  Scand J Immunol       Date:  1983-05       Impact factor: 3.487

4.  Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7.

Authors:  D Catovsky; M Cherchi; D Brookss; J Bradely; H Zola
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

Review 5.  Clinical patterns in B lymphoid malignancy.

Authors:  D A Galton; I C MacLennan
Journal:  Clin Haematol       Date:  1982-10

Review 6.  The normal and malignant germinal centre.

Authors:  H Stein; J Gerdes; D Y Mason
Journal:  Clin Haematol       Date:  1982-10

7.  Surface immunoglobulin density on human peripheral blood mononuclear cells.

Authors:  R B Slease; R Wistar; I Scher
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

8.  Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.

Authors:  J Ritz; L M Nadler; A K Bhan; J Notis-McConarty; J M Pesando; S F Schlossman
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

9.  Prolymphocytic transformation of chronic lymphocytic leukemia.

Authors:  C R Kjeldsberg; J Marty
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

Review 10.  Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.

Authors:  M F Greaves; G Hariri; R A Newman; D R Sutherland; M A Ritter; J Ritz
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

View more
  3 in total

1.  Proposed relation between expression of interleukin-2 and transferrin receptors in B lymphocyte chronic lymphocytic leukaemia.

Authors:  D Barnett; G A Wilson; A C Lawrence; G A Buckley
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

2.  Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumours.

Authors:  R A Jones; C S Scott; D R Norfolk; A N Stark; J A Child
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

3.  Morphological and immunological changes of hairy cell leukemia during alpha-2-interferon therapy.

Authors:  M A Fridrik; G Wahl; W Herbinger; W Schützenberger; G Gastl; C Huber; M Krönke; I Höpfel
Journal:  Blut       Date:  1989-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.